Viewing nowCombinationSeviruca Tablet 5/20 mg (Amlodipine, Olmesartan)
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202003824 · Approved 2020.05.26 · Insurance code 694004500
Treatment of essential hypertension not controlled with monotherapy
Patients with essential hypertension can be treated with either amlodipine or olmesartan medoxomil alone. This medication is used when blood pressure is not adequately controlled. The two drugs effectively manage hypertension by either dilating blood vessels or inhibiting blood pressure increases. As a result, they help stabilize blood pressure and reduce the risk of complications. This treatment method is used for the improvement of hypertension.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or olmesartan medoxomil) be adjusted before starting this medication. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medication may be considered. The maximum dose of this medication is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This medication has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily. Use of this medication is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be closely monitored. This medication should not be administered to patients with severe hepatic impairment. (See section 2, “Patients who should not receive this medication,” under Precautions for Use.) ∘Elderly patients: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In elderly patients, blood pressure should be monitored closely and more frequently.
∘Children: The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients in this medication or similar drugs, those who are pregnant or breastfeeding, individuals with severe liver or kidney damage, specific cardiac diseases, patients with bile duct obstruction, those undergoing kidney dialysis, individuals in a state of shock, certain diabetic patients, and those with moderate to severe renal impairment, as well as individuals with genetic issues such as lactose intolerance, should avoid taking this drug. Patients with low blood pressure due to insufficient bodily fluids or salt may experience initial symptoms of low blood pressure when taking this medication, so they must monitor their condition closely, and if hypotension occurs, they should be laid down and receive intravenous fluids if necessary. This medication acts to dilate blood vessels and should be used with caution in patients with acute hypotension or heart-related conditions. In patients with impaired kidney function or liver function, this drug may have effects on the kidneys or liver, so it should be used cautiously. When taking this medication, side effects such as dizziness, headache, drowsiness, hypotension, dyspepsia, skin rash, and edema may occur, so it is important to consult with healthcare professionals if any unusual symptoms arise. It is advisable not to take this medication during pregnancy, and if breastfeeding, caution should be exercised as it can be transmitted into breast milk and affect the infant, so the decision to take this medication should be made carefully. This medication is not recommended for children as safety and efficacy have not been established. Elderly patients may have decreased liver, kidney, or heart function, so extra caution should be exercised when taking this medication, and it is generally suggested to start with lower doses. Overdose of this medication may lead to severe hypotension, vasodilation, tachycardia, etc., so the prescribed dosage must be adhered to strictly, and in case of overdose, immediate medical attention should be sought. This medication should be stored in a tightly closed container away from direct sunlight and moisture, and it is advisable not to transfer it to another container. Interactions with other medications may occur when taking this drug, so it is essential to inform healthcare providers of any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from exposure to air or moisture. It is critical to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the efficacy and safety of the medication.
White round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.